A new study co-authored by a Northwestern Medicine scientist found no significant difference between two popular therapy regimens in patients with a subset of Hodgkin lymphoma.
A study co-authored by Northwestern Medicine scientist Rintaro Hashizume, MD, PhD, identified the EAG2 potassium channel as a target for treating medulloblastoma.
A multi-center team of scientists have received funding from the National Cancer Institute to develop compounds that may lead to an entirely new treatment for Acute Myeloid Leukemia (AML). The grant, which will provide $1.58 million over three years, will support medicinal chemistry, molecular modeling, and biological testing to optimize small molecule CXCR4-receptor antagonists and…
Northwestern University has received a five-year, $11.7 million grant from the National Cancer Institute to use nanotechnology to develop next-generation cancer treatments.
Behnam Nabet, ’15 PhD, who just completed his doctorate in the Driskill Graduate Program in Life Sciences, studied how mutated Ras genes turn normal cells into cancer cells in a new publication.
Northwestern Medicine scientists have discovered how a gene linked to leukemia functions, a finding that may have important implications for children with Down syndrome who have a higher risk of developing the blood cancer.
A study coauthored by Northwestern Medicine scientists found that normal cells stop proliferating when they lose important intracellular structures called centrioles, but cancer cells continue to multiply.
Medical Scientist Training Program students and twin sisters Lauren Smith, ’15 PhD, and Adrienne Long, ’15 PhD, discuss their recently published research projects and their futures as physician-scientists.
A new study suggests a toxin responsible for seafood-associated sepsis and necrotizing fasciitis may have the ability to treat cancer by destroying the protein Ras.
The impossible is possible when cancer survivors are monitored by medical professionals who know their specialized needs.